Cabergoline is a dopaminergic derivative of ergoline and is characterized by a pronounced and long-lasting prolactin-lowering effect. Cabergoline affects the body by direct stimulation of D2-dopamine receptors on lactotroph cells in the pituitary gland. In bodybuilding, the drug is used to lower prolactin levels and eliminate the unwanted side effects of the anabolic supplement.